Randomized phase III study of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT)

被引：54

作者：

Von Hoff, Daniel D.

Ervin, Thomas J.

Arena, Francis P.

Chiorean, E. Gabriela

Infante, Jeffrey R.

Moore, Malcolm J.

Seay, Thomas E.

Tjulandin, Sergei

Ma, Wen Wee

Saleh, Mansoor N.

Harris, Marion

Reni, Michele

Ramanathan, Ramesh K.

Tabernero, Josep

Hidalgo, Manuel

Van Cutsem, Eric

Goldstein, David

Wei, Xinyu

Iglesias, Jose Luis

Renschler, Markus Frederic

机构：

[1] Scottsdale Healthcare TGen, Virginia G Piper Canc Ctr, Scottsdale, AZ USA

[2] Florida Canc Specialists, Englewood, FL USA

[3] Arena Onc Associates, Success, NY USA

[4] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA

[5] Sarah Cannon Canc Ctr, Nashville, TN USA

[6] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[7] Univ Toronto, Toronto, ON, Canada

[8] Atlanta Canc Care, Atlanta, GA USA

[9] Russian Acad Med Sci, NN Blokhin Canc Res Ctr, Moscow, Russia

[10] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

[11] Georgia Canc Specialists, Georgia, GA USA

[12] Southern Hlth, East Bentleigh, Australia

[13] Ist Sci San Raffaele, I-20132 Milan, Italy

[14] Vall dHebron Univ Hosp, Barcelona, Spain

[15] START Madrid, Ctr Integral Oncol Clara Campal, Madrid, Spain

[16] Leuven Canc Inst LKI, Leuven, Belgium

[17] Prince Wales Hosp, Sydney, NSW, Australia

[18] Celgene Corp, Summit, NJ USA

[19] Bionomics Ltd, Thebarton, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 04期

关键词：

D O I：

10.1200/jco.2013.31.4_suppl.lba148

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA148

引用

页数：1